By Emily Field ( May 3, 2017, 9:11 PM EDT) -- The Tenth Circuit on Tuesday partially upheld a lower court's decision that tossed a mother's claim Aventis' infertility drug Clomid failed to adequately warn about birth defects because the U.S. Food and Drug Administration had previously rejected such warnings, but sent fraud and other claims back to the lower court in Utah....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.